Session » Innate Immunity Poster

Date: Monday, October 22, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1027

A Novel IL-1 Mediated Autoinflammatory Disease Caused By a Specific Gain-of-Function Mutation in Dysferlin

9:00AM-11:00AM: Abstract Number: 1032

Aberrant Sarcoplasmic Expression of the Alarmin ‘High Mobility Group Box Protein 1” (HMGB1) in Patients with Idiopathic Inflammatory Myopathy

9:00AM-11:00AM: Abstract Number: 1028

An Entheseal Innate Immune Cell Biological Basis for Differential Efficacy of PDE4 and IL-23 Pathway Blockade between Psoriatic Disease and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1017

Autoantigen Pentraxin-3 Is an Inflammatory Cytokine Storms Suppressor By Switching Monocytes Pyroptosis to Apoptosis in a Complement-Dependent Manner in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1026

Autoinflammatory Diseases, Particularly SAVI and Candle, Are Driven By Chronically Active Type I Interferons

9:00AM-11:00AM: Abstract Number: 1013

Circulating Hybrid M1/M2 Monocytes/Macrophages in Systemic Sclerosis Patients with Lung Involvement

9:00AM-11:00AM: Abstract Number: 1014

Distinct Macrophage Phenotype and Bioenergetic Profiles in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1029

Fibroblast-like Synoviocytes As Immune Effectors in the Pathogenesis of Synovial Lesion in Antibiotic-Refractory Lyme Arthritis

9:00AM-11:00AM: Abstract Number: 1021

Impact of TLR7 Ligation in RA Pathology

9:00AM-11:00AM: Abstract Number: 1010

Inhibition of Bruton’s Tyrosine Kinase (BTK) Prevents Inflammatory Macrophage Differentiation: A Potential Role in RA and SLE

9:00AM-11:00AM: Abstract Number: 1012

Inhibition of Inflammation and Oxidative Stress in Systemic Sclerosis (SSc) Macrophages

9:00AM-11:00AM: Abstract Number: 1019

Involvement of Mast Cells in the Pathogenesis of Sjögren’s Syndrome By Induction of Tissue Fibrosis Via Fibroblast Collagen Synthesis

9:00AM-11:00AM: Abstract Number: 1020

Involvement of Toll-like-Receptor-9 Pathway on Natural Killer Cells in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1007

Macrophage Mediators of Autoimmune Valvular Carditis and Fibrosis

9:00AM-11:00AM: Abstract Number: 1025

MiR-146a a Key Player in Bone Metabolism

9:00AM-11:00AM: Abstract Number: 1009

Monocytes Membrane TNF Expression and Anti-TNF Treatment in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1003

Neutrophil Response to Ultraviolet Light in Normal and Lupus Conditions

9:00AM-11:00AM: Abstract Number: 1031

Orally Administered Cherry Juice Inhibits Localized Nfκb Activity and Histopathological Infiltrates in a Murine Model of Gout

9:00AM-11:00AM: Abstract Number: 1030

Parenteral Injection of Human Adipose-Derived Mesenchymal Stem Cells Attenuates Inflammation in an Acute Model of Gouty Arthritis

9:00AM-11:00AM: Abstract Number: 1006

Physical Activity at Lower Intensities Reduces Localized IL-1b in a Murine Model of Gout By Systemically Down-Regulating TLR2 Expression on Circulating Neutrophils and Suppressing CXCL1 Expression

9:00AM-11:00AM: Abstract Number: 1002

Pkcα Deficiency Protected Mice from UVB Induced-Skin Inflammation through Attenuation of Neutrophil Netosis

9:00AM-11:00AM: Abstract Number: 1023

Plasmacytoid Dendritic Cells That Infiltrate the Lungs Produce Profibrotic Cytokines and Chemokines in Bleomycin-Induced Model of Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1008

Presence of a Specific Defect in M2 Polarization of Blood Monocytes from Patients with Rheumatoid Arthritis, Associated with Increased microRNA-155

9:00AM-11:00AM: Abstract Number: 1004

Reevaluating Citrullination and Peptidylarginine Deiminases in Neutrophil Extracellular Trap-like Structures

9:00AM-11:00AM: Abstract Number: 1005

Regulation of Neutrophil Activation in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1015

Rheumatoid Arthritis Peripheral CD14+ Monocytes Are Hyper-Inflammatory, Hyper-Glycolytic and Retain a Memory Bias Toward M1 Macrophages

9:00AM-11:00AM: Abstract Number: 1016

The Distinct Profile of Ly6clo Monocytes in the Murine Joint Compared with Those in Circulation Suggests a Unique Role in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1011

Tissue Resident Macrophages Establish a Niche That Limits Monocyte to Macrophage Differentiation in Synovial Tissue during Homeostasis

9:00AM-11:00AM: Abstract Number: 1022

TNF-α Regulates Plasmacytoid Dendritic Cells By Suppressing IFN-α Production and Enhancing Th1 and Th17 Cell Differentiation

9:00AM-11:00AM: Abstract Number: 1018

Tofacitinib Impairs Monocyte-Derived Dendritic Cell Differentiation in Rheumatoid Arthritis and Psoriatic Arthritis.

9:00AM-11:00AM: Abstract Number: 1024

Unique Pattern of Lectin Pathway Complement Protein Levels in Axial Spondyloarthritis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].